|
32
|
133
|
7g20A |
Crystal structure of human fabp4 in complex with 1-[(4-methoxyphenyl)methyl]-5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione |
|
34
|
129
|
7g1xA |
Crystal structure of apo human fabp1 - monoclinic form i |
|
28
|
130
|
7g0oA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
|
32
|
133
|
7g1sA |
Crystal structure of human fabp4 in complex with 3-(3,4-dichlorophenyl)-3,7a-dihydro-1h-imidazo[1,5-c][1,3]thiazole-5,7-dione |
|
29
|
134
|
7fxuA |
Crystal structure of human fabp4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
32
|
134
|
7g08A |
Crystal structure of human fabp4 in complex with 2-(3-chloro-2-methylanilino)benzoic acid |
|
32
|
135
|
7g06A |
Crystal structure of human fabp4 in complex with 5-(chloromethyl)-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
32
|
134
|
7g02A |
Crystal structure of human fabp4 in complex with 7-methoxy-1-(3-methoxyphenyl)naphthalene-2-carboxylic acid |
|
31
|
133
|
7fzzA |
Crystal structure of human fabp4 in complex with 3-[(2,4-dichloro-5-methylphenyl)sulfonylamino]thiophene-2-carboxamide |
|
33
|
134
|
7fvuA |
Crystal structure of human fabp4 in complex with 2-[2-(benzothiophen-3-yl)-2,3-dihydrobenzothiophene-3-carbonyl]benzoic acid |
|
29
|
135
|
7g0iA |
Crystal structure of human fabp4 in complex with 5-phenoxy-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
34
|
135
|
7g0fA |
Crystal structure of human fabp4 in complex with 6-[(3-methoxycarbonyl-4-thiophen-2-ylthiophen-2-yl)carbamoyl]cyclohex-3-ene-1-carboxylic acid |
|
31
|
133
|
7fvwA |
Crystal structure of human fabp4 in complex with 2-[2-(3-chlorophenyl)ethyl]-1,3-thiazole-4-carboxylic acid |
|
32
|
133
|
7fxfA |
Crystal structure of human fabp4 in complex with 2-[(2-chlorophenoxy)methyl]-1,3-thiazole-4-carboxylic acid |
|
30
|
133
|
7fy5A |
Crystal structure of human fabp4 in complex with 2,5,5-trimethyl-6,7,8,9-tetrahydrobenzo[7]annulene-3-carboxylic acid |
|
31
|
135
|
7fybA |
Crystal structure of human fabp4 in complex with rac-(1r,2s,4r)-2-[(3-chlorobenzoyl)amino]-4-phenoxycyclohexane-1-carboxylic acid |
|
34
|
127
|
7g00A |
Crystal structure of human fabp1 in complex with 2-[[3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
30
|
134
|
7fyvA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-9-methyl-3-oxa-4-azatricyclo[5.2.1.02,6]dec-4-ene-8-carboxylic acid |
|
31
|
133
|
7fyeA |
Crystal structure of human fabp4 in complex with 1-[(4-chlorophenyl)methyl]-4-hydroxypyridin-2-one |
|
33
|
134
|
7fzsA |
Crystal structure of human fabp4 in complex with 6-chloro-4-[(2-chlorophenyl)methyl]-2-methylquinoline-3-carboxylic acid |
|
32
|
133
|
7g1bA |
Crystal structure of human fabp4 in complex with 2-[1-[(3-chlorophenyl)methyl]indol-2-yl]cyclopropane-1-carboxylic acid |
|
29
|
130
|
7fx7A |
Crystal structure of human fabp4 with binding site mutated to fabp5 in complex with 5-methylsulfanyl-2-[(4-phenylmethoxy-1h-indazol-3-yl)methylsulfanyl]pyrimidin-4-ol |
|
32
|
135
|
7fxvA |
Crystal structure of human fabp4 in complex with 6-[(4-methoxyphenyl)methyl]-2h-1,2,4-triazine-3,5-dithione |
|
33
|
134
|
7g1qA |
Crystal structure of human fabp5 in complex with (1s,2r)-2-[(5-carbamoyl-3-ethoxycarbonyl-4-methyl-2-thienyl)carbamoyl]cyclohexanecarboxylic acid |
|
28
|
134
|
7g0zA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 5-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-4-carboxylic acid |
|
35
|
134
|
7fvxA |
Crystal structure of human fabp4 in complex with 4-(1-methyl-2-phenylindol-3-yl)cyclohexane-1-carboxylic acid |
|
28
|
134
|
7fy1A |
Crystal structure of apo human fabp9 |
|
31
|
134
|
7fygA |
Crystal structure of human fabp4 in complex with 6-benzyl-2h-1,2,4-triazine-3,5-dithione |
|
30
|
133
|
7g1gA |
Crystal structure of human fabp4 in complex with 2-(2-hydroxy-3,5,5,8,8-pentamethyl-3,4,4a,6,7,8a-hexahydro-1h-naphthalen-2-yl)acetic acid |
|
32
|
133
|
7g1zA |
Crystal structure of human fabp4 in complex with 5-[(4-chloro-3-phenoxyphenyl)methyl]-1h-tetrazole |
|
30
|
134
|
7g05A |
Crystal structure of human fabp4 in complex with 2,6-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenol |
|
32
|
133
|
7g16A |
Crystal structure of human fabp4 in complex with 6-bromo-3-hexyl-2-oxo-3,4-dihydro-1h-quinoline-4-carboxylic acid |
|
31
|
133
|
7g0gA |
Crystal structure of human fabp4 in complex with 5-(3-bromo-4-methylphenyl)-3,3-dimethyl-5-oxopentanoic acid |
|
32
|
134
|
7fwnA |
Crystal structure of human fabp4 in complex with 3-(5-methyl-2,3-diphenylindol-1-yl)propanoic acid |
|
32
|
133
|
7fzcA |
Crystal structure of human fabp4 in complex with 5-[(2-chlorophenoxy)methyl]-4-propan-2-yl-1,2,4-triazole-3-thiol |
|
31
|
133
|
7fwkA |
Crystal structure of human fabp4 in complex with 1-[(2-chlorophenyl)methyl]pyrrole-2-carboxamide |
|
32
|
134
|
7fzbA |
Crystal structure of human fabp4 in complex with 2-[5-methyl-2-(1-methylcyclohexyl)-1,3-oxazol-4-yl]acetic acid |
|
31
|
134
|
7fvvA |
Crystal structure of human fabp4 in complex with (1s,2r)-2-[(5-carbamoyl-3-ethoxycarbonyl-4-methyl-2-thienyl)carbamoyl]cyclohexanecarboxylic acid |
|
33
|
133
|
7fw1A |
Crystal structure of human fabp4 in complex with 2-cyclopentyl-4-(4-fluorophenyl)-6-[1-(methoxymethyl)cyclopentyl]-3-methyl-5-(1h-tetrazol-5-yl)pyridine |
|
31
|
133
|
7fwyA |
Crystal structure of human fabp4 in complex with 2-[(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)sulfanyl]acetic acid |
|
33
|
133
|
7fznA |
Crystal structure of human fabp4 in complex with (1s,2s,5r)-3-(2-thiophen-3-ylacetyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid |
|
29
|
133
|
7fwcA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-2-(hydroxymethylene)cyclohexane-1,3-dione |
|
31
|
134
|
7fx0A |
Crystal structure of human fabp4 in complex with 5-[(2-chloroanilino)methyl]-4-ethyl-1,2,4-triazole-3-thiol |
|
33
|
134
|
7fxxA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
31
|
134
|
7g0mA |
Crystal structure of human fabp4 in complex with 2-tert-butylsulfanyl-6-phenyl-1h-1,3,5-triazine-4-thione |
|
25
|
129
|
7fx3A |
Crystal structure of apo human fabp4, tetragonal form |
|
30
|
133
|
7fypA |
Crystal structure of human fabp4 in complex with (1s,2s)-2-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxycarbonylcyclopropane-1-carboxylic acid |
|
32
|
130
|
7g12A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with n-methyl-6-(3-methylthiophen-2-yl)-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
33
|
134
|
7g10A |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 1-[(4-chloro-2-phenoxyphenyl)methyl]-4-hydroxypyridin-2-one |
|
31
|
135
|
7fyjA |
Crystal structure of human fabp4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
